Genaissance Pharmaceuticals, Inc. Invites You to Participate in Its Third Quarter 2002 Conference Call
Tuesday November 5, 3:21 pm ET
NEW HAVEN, Conn., Nov. 5 /PRNewswire-FirstCall/ -- In conjunction with the release of its financial results for the third quarter ended September 30, 2002, management of Genaissance Pharmaceuticals (Nasdaq: GNSC - News), will conduct a conference call:
Tuesday, November 12, 2002
11:00 a.m. Eastern
To participate in this call,
dial: 913-981-5522
confirmation code: 716060
shortly before 11:00 a.m. Eastern
To reserve a line,
please call Rhonda Chiger at Rx Communications Group, LLC
917-322-2569.
A replay of the call will be available from 2:00 p.m. Eastern through midnight Monday, November 18th, 2002. The replay number is 719-457-0820, confirmation code 716060.
Genaissance Pharmaceuticals, Inc. is the world leader in the discovery and use of human gene variation for the development of personalized medicines. The Company markets its technology and clinical development skills to the pharmaceutical industry as a complete solution for improving the development, marketing and prescribing of drugs. Genaissance has agreements with three of the top five pharmaceutical companies as well as one of the premier biopharmaceutical companies: AstraZeneca, Biogen, Johnson & Johnson and Pfizer. Genaissance is located in Science Park in New Haven, Connecticut. |
